Physician profile
Jillian M Peragallo
NPI 1376944231
$3,482.38
in general payments reported to CMS, 2019-2025
19 companies · $1,361 in 2025
The $1,361 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $94.43 · 2023: $747 · 2024: $1,280 · 2025: $1,361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,387.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,075.89 | 2022-2025 | |
| Mml US, INC. | $461.23 | 2023-2024 | Reactiv8 |
| Medtronic, INC. | $435.78 | 2024-2025 | Inceptiv, Intellis Adaptivestim, Accurian |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $375.40 | 2022-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $271.41 | 2022-2025 | Belbuca, Xtampza |
| Forte Bio-Pharma LLC | $236.66 | 2023-2025 | Prolate, Nalocet, Tanlor |
| Nalu Medical, INC. | $103.32 | 2023 | Nalu Neurostimulation System |
| Azurity Pharmaceuticals, INC. | $83.23 | 2022-2025 | Horizant |
| Pfizer INC. | $81.39 | 2023-2025 | |
| Si-Bone, INC. | $65.87 | 2023-2024 | |
| Valinor Pharma, LLC | $65.58 | 2024-2025 | Movantik |
| Lundbeck LLC | $52.74 | 2025 | Vyepti |
| Avanos Medical | $29.97 | 2025 | Coolief Cooled Radiofrequency |
| Protega Pharmaceutials INC | $28.25 | 2024 | Roxybond |
| Amgen INC. | $25.32 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $25.00 | 2023 | Senza |
| Ipsen Biopharmaceuticals, INC | $24.14 | 2025 | Dysport |
| Ibsa Pharma INC. | $21.61 | 2025 | Tirosint, Licart, Flector |
| Averitas Pharma INC. | $19.59 | 2025 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jillian Peragallo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.